To test whether the chemokine receptor CXCR3, expressed on the CD431B11+T cell subset and known to mediate adhesion induction,53 was also implicated in tumor migration, we blocked this chemokine receptor by antibodies provided during PDOX treatment of tumor-challenged mice (Figure 7I). Here, CXCR3 is linked to neoplasm.